维普期刊资源整合服务平台（V6.5）

29篇 您的检索式：作者名="KNAPPER S"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	A phase 2 trial of the FLT3 inhibitor lestaurtinib ( CEP701 ) as first-line treatment for older patients with acute myeloid leukemia not considered fit for intensive chemotherapy 显示文摘	Knapper S Bumett AK Littlewood T	2006	Blood2006，108，10：	1
2	A phase 2 trial of the flt3 inhibitor lestaurtinib(CEP701) as first line treatment for older patients with acute myeloid leukemia not considered fit for intensive chemotherapy显示文摘	Knapper S Burnett AK	2006	Blood2006，108，：	1
3	A phase 2 trial of the FLT3 inhibitor lestaurtinih (CEPTOI) as first-line treatment for older patients with acute myeloid leukemia not considered fit for intensive chemotherapy显示文摘	Knapper S Burnett AK Littlewood T	2006	Blood2006，108，10：	1
4	The effects of lestaur- tinib (CEP701) and PKC412 on primary AM1 blasts: the in- duction of cytotoxicity varies with dependence on FLT3 signa- ling in both FLT3-mutated and wild-type cases 显示文摘	Knapper S Mills KI Gilkes AF	2006	Blood2006，108，10：	1
5	Human ATP-binding cassette transporter 1 (ABC1):genomic organization and identification of the genetic defect in the original Tangier disease kindred显示文摘	Remaley AT Rust S Rosier M Knapper C Naudin L Broccardo C		0，，：	1
6	A phase 2 trim of the FLT3 inhibitor lestaurtinib( CEP701 )as first-line treatment for ol- der patients with acute myeloid leukemia not considered fit for in- tensive chemotherapy 显示文摘	Knapper S Bumett AK Littlewood T	2006	Blood2006，108，10：	1
7	A phase 2 trial of the FLT3 inhibitor lestaurtinib (CEP701) as first-line treatment for older patients with acute myeloid leukemia not considered fit for intensive chemotherapy 显示文摘	Knapper S Bumett AK Littlewood T	2006	Blood2006，108，10：	1
8	The clinical development of FLT3 inhibitors in acute my- eloid leukemia显示文摘	Knapper S	2011	Expert Opin Investig Drugs2011，20，10：	1
9	FLT3 ligand impedes the efficacy of FLT3 inhibitors in vitro and in vivo显示文摘	Sato T Yang X Knapper S	2011	Blood2011，117，12：	1
10	Complete genomic sequence of the human ABCA1:analysis of the human and mouse ATP-binding cassatte a promoter显示文摘	PTERSON K KNAPPER C	2000	Proc Natl Acad Sci USA2000，97，：	1
11	FLT3 ligand impedes the efficacy of FLT3 inhibitors in vitro and in vivo 显示文摘	Sato T Yang X Knapper S	2011	Blood2011，117，12：	1
12	A phase 2trial of the FLT3inhibitor lestaurtinib(CEP701)as first-line treatment for older patients with acute myeloid leukemia not considered fit for intensive chemotherapy显示文摘	Knapper S Burnett AK Littlewood T	2006	Blood2006，108，：	1
13	Complete genomic sequence of the human ABCA1 gene, Analysis of the human and mouse ATP-binding cassette A promoter显示文摘	Santamarina-Fojo S Peterson K Knapper C	2000	Proc Natl Acad Sci USA2000，97，14：	1
14	FLT3 ligand impedes the efficacy of FLT3 inhibitors in vitro and in vivo 显示文摘	Sato T Yang X Knapper S	2011	Blood2011，117，12：	1
15	FLT3 ligand impedes the efficacy of FLT3 inhibitors in vitro and in vivo显示文摘	Sato T Yang X Knapper S	2011	Blood2011，117，12：	1
16	Complete genomic sequence of the human ABCA1 :analysis of the human and mouse ATP-binding cassatte A promoter显示文摘	Santamarina-fojo S Pterson K Knapper C	2000	Proc Natl Acad Sci USA2000，97，：	1
17	FLT3ligand impedes the efficacy of FLT3inhibitors in vitro and in vivo显示文摘	Sato T Yang X Knapper S	2011	Blood2011，117，：	1
18	Complete genomic sequence of the human ABCA1: Analysis of the human and mouse ATP-binding cassatte a promoter 显示文摘	Santamarina-fojo S Pterson K Knapper C	2000	Proc Natl Acad Sci USA2000，97，：	1
19	Novel therapies for children with acute myeloid leukaemia显示文摘	Moore AS Keams PR Knapper S		0，，：	1
20	A phase 2 trial of the FLT3 inhibitor lestaurtinib (CEPT01) as first-line treatment for older patients with acute myeloid leukemia not considered fit for intensive chemotherapy显示文摘	KNAPPER S BURNETT A K LITTLEWOOD T	2006	Blood2006，108，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示